Related Experiment Videos
Goals and guidelines for treating hypertension in a patient with heart failure
Douglas S Lee1, Ramachandran S Vasan
1Framingham Heart Study, 73 Mt. Wayte Avenue, Suite 2, Framingham, MA 01702-5827, USA.
Insights
Controlling hypertension is crucial for patients with heart failure, as it can reduce left ventricular hypertrophy and improve outcomes. Lower blood pressure targets may be beneficial for those with diabetes or kidney disease.
Area of Science:
- Cardiology
- Nephrology
- Hypertension Research
Background:
- Hypertension is a significant factor in left ventricular (LV) hypertrophy and myocardial remodeling.
- It is commonly observed in patients experiencing systolic or diastolic heart failure.
- Effective hypertension management may mitigate progressive LV hypertrophy and remodeling, leading to better clinical outcomes.
Purpose of the Study:
- To summarize current guidelines on hypertension management in heart failure patients.
- To outline recommended blood pressure targets and pharmacologic treatments.
- To identify medications to avoid and potential interventions for renovascular disease.
Main Methods:
- Review of existing clinical guidelines for heart failure and hypertension management.
- Analysis of recommended blood pressure targets based on comorbidities.
- Evaluation of first-line and contraindicated pharmacologic agents for hypertension in heart failure.
Main Results:
- Hypertension treatment is recommended for all heart failure stages (preclinical, reduced or preserved LV function).
- Target blood pressure is <140/90 mm Hg, with <130/80 mm Hg suggested for patients with diabetes or renal disease.
- Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and beta-blockers are recommended; calcium channel blockers and doxazosin should be avoided.
Conclusions:
- Aggressive blood pressure control in hypertensive heart failure patients can attenuate LV hypertrophy and remodeling.
- Specific drug classes are recommended for first-line treatment, while others should be avoided.
- Recurrent pulmonary edema and hypertension may signal renovascular disease treatable with percutaneous renal artery intervention.
Abstract:
Hypertension promotes left ventricular (LV) hypertrophy and myocardial remodeling and is frequently present in patients with systolic or diastolic heart failure. Control of hypertension in both of these settings may attenuate progressive LV hypertrophy and remodeling and improve clinical outcomes. Guidelines for the management of heart failure recommend that hypertension should be treated in all patients with preclinical heart failure as well as in those with heart failure with reduced or preserved LV systolic function. Consistent with national hypertension guidelines, the goal for blood pressure control in hypertensive patients with heart failure is less than 140/90 mm Hg, but lower targets (< 130/80 mm Hg) may be desirable in those with concomitant diabetes mellitus or renal disease. Angiotensin-converting enzyme inhibitors, angiotensin II receptor antagonists, and beta-adrenoreceptor antagonists are first-line options for hypertension treatment in heart failure. Calcium channel antagonists and the alpha blocker doxazosin should be avoided. Episodes of recurrent pulmonary edema and hypertension may also indicate underlying severe renovascular disease that may respond to percutaneous renal artery intervention.
Related Concept Videos
Heart Failure VI: Adjunct Therapies
Heart Failure V: Medical Management
Heart Failure VII: Nursing Interventions
Hypertension V: Nursing Management
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Hypertension IV: Drug Therapy and Lifestyle Modifications